MedLinks, a leading Indian centre for hair and skin sciences, has launched Elyara Hair Filler, a peptide-based injectable treatment, to address the growing demand for non-surgical, science-backed hair restoration solutions. The treatment is now available at MedLinks clinics in New Delhi and Gurugram.
Growing Demand for Non-Surgical Solutions
Hair loss affects a significant portion of the population. Research indicates that nearly 50% of men experience male-pattern hair loss by age 50, while approximately 40% of women face visible hair loss by the same age. Beyond physical appearance, hair loss can impact confidence and quality of life, driving more individuals to seek early intervention.
Patients are increasingly informed about treatment options and expect outcomes backed by science. They prefer solutions that work with the body's natural biological processes and can be part of a long-term hair restoration strategy. This shift has spurred interest in regenerative and personalized treatment pathways.
Understanding Hair Loss and Peptide Technology
Hair loss is often driven by dihydrotestosterone (DHT), a hormone derived from testosterone. DHT triggers biological signals such as increased DKK-1 and BMP4 activity, which can suppress Wnt signaling, contribute to hair follicle miniaturization, and lead to progressive thinning. Peptides, short chains of amino acids, act as biological messengers that regulate cellular activities. In hair restoration, peptide-based formulations are explored for their potential to support follicle function, scalp health, and the natural hair growth cycle.
Elyara Hair Filler: Composition and Mechanism
Elyara Hair Filler combines seven patented biomimetic peptides that work synergistically to stimulate hair follicles, support key pathways such as Wnt signaling, protect follicles from oxidative stress, and promote scalp microcirculation. The formulation is designed to address multiple biological processes involved in hair growth.
Dr. Gaurang Krishna, Director and Co-founder of MedLinks, stated: "Hair restoration is no longer a one-size-fits-all approach. Patients today are far more informed about the treatments they choose and the outcomes they expect. Increasingly, they are looking for solutions that are backed by science, align with the body's natural processes, and can be incorporated into a long-term hair restoration strategy."
Expert Perspectives
Dr. Varun Gupta, Founder and CEO of Elyara by MedVital, added: "Hair biology is regulated by multiple signalling pathways rather than a single mechanism. Elyara Hair Filler is designed to support several biological processes associated with hair follicle function, scalp health, and the natural hair growth cycle. We are pleased to collaborate with leading hair restoration clinics such as MedLinks that are committed to evidence-based innovation."
Comprehensive Care at MedLinks
MedLinks offers both surgical and non-surgical treatment options under one roof. The introduction of Elyara Hair Filler strengthens its ability to provide physician-administered treatments tailored to individual patient needs and stages of hair loss. The clinic serves patients from across India and over 25 countries.
About MedLinks and Elyara
Founded in 2013 by alumni of AIIMS, New Delhi, MedLinks is a centre for hair restoration, aesthetic dermatology, and regenerative medicine. Elyara by MedVital is a regenerative aesthetics platform focusing on science-backed solutions for hair restoration and aesthetic medicine. Its flagship product, Elyara Hair Filler, uses seven patented biomimetic peptides with sustained-release technology.
This development reflects a broader trend toward personalized and non-surgical approaches in hair restoration, as patients increasingly seek evidence-based, minimally invasive treatments.
